Mark Hazeltine - Feb 8, 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Chief Business Officer
Signature
/s/ Kamal Adawi, as attorney-in-fact
Stock symbol
XGN
Transactions as of
Feb 8, 2023
Transactions value $
-$15,672
Form type
4
Date filed
2/10/2023, 03:08 PM
Previous filing
Mar 2, 2022
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Sale -$15.7K -5.82K -5.84% $2.69 93.9K Feb 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.